| Literature DB >> 35773331 |
Lin Li1, Qin Yang2, Qi Guo3, Dandan Liu1, Hui Gao1, Yaping Liu4.
Abstract
The purpose of this study is to evaluate the relationship between preoperative physical performance (grip strength, gait speed, timed up and go) and postoperative pulmonary complications (PPCs) in patients who have undergone coronary artery bypass grafting (CABG). From September 2019 to August 2021, a total of 497 CABG patients who met the inclusion criteria of this study were examined for grip strength, 4-m gait speed, and timed up and go (TUG) before CABG surgery. Among them, 438 were included in the final analysis. PPCs were classified according to the operational definition of Kroenke et al. and patients with clinically significant PPCs were included in the data analysis. Logistic regression was utilised to analyse the relationship between physical performance and clinically significant PPCs. Besides, the receiver operating characteristic (ROC) curve was applied to analyse the predictive effect of grip strength, gait speed, and TUG on clinically significant PPCs after the CABG procedure. In total, 103 (23.5%) patients developed clinically significant PPCs after CABG. After making adjustments for the European System for Cardiac Operative Risk Evaluation (EuroSCORE) and confounding factors, we established that low grip/weight (OR 0.510; 95% CI 0.363-0.715), slow gait speed (OR 0.619; 95% CI 0.517-0.741), and prolonged TUG (OR 1.617; 95% CI 1.379-1.895) were all independently correlated with clinically significant PPCs after CABG. The ROC curve analysis indicated that the area under the ROC curve of the integrated model of the three indicators (AUC 0.792 vs. 0.682, 0.754, 0.765) was larger than that of the model with a single indicator. Besides the predictive effect of the integrated model was superior to the models using grip/weight, gait speed, or TUG alone. Physical performance, including grip/weight, gait speed, and TUG, is a predictive factor for PPCs in CABG patients, and can be used in preoperative evaluations to and help improve the management of high-risk patients.Entities:
Mesh:
Year: 2022 PMID: 35773331 PMCID: PMC9246884 DOI: 10.1038/s41598-022-15145-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Flow diagram of patient selection and study design.
Clinical characteristics of the patients with and without clinically significant PPCs.
| Characteristics | Control ( | Clinically significant PPCs ( | Statistics | |
|---|---|---|---|---|
| Age (y) | 62.84 ± 8.39 | 65.41 ± 8.10 | 0.020 | |
| Female (n, %) | 85 (25.4) | 39 (37.9) | 0.014 | |
| BMI (kg/m2) | 25.84 ± 3.29 | 25.38 ± 3.18 | 0.205 | |
| Heart rate (bpm) | 73.55 ± 11.66 | 69.77 ± 11.64 | 0.004 | |
| Farmer (n, %) | 119 (35.5) | 49 (47.6) | 0.085 | |
| Illiteracy (n, %) | 27 (8.1) | 6 (5.8) | 0.143 | |
| Smoker (n, %) | 103 (30.7) | 48 (46.6) | 0.003 | |
| Drinker (n, %) | 82 (24.5) | 22 (21.4) | 0.515 | |
| EuroSCORE | 4.62 ± 1.86 | 5.46 ± 1.69 | < 0.001 | |
| Hemoglobin (g/l) | 135.62 ± 14.93 | 134.32 ± 14.55 | 0.436 | |
| Serum Albumin (g/dl) | 4.23 ± 0.50 | 4.14 ± 0.45 | 0.108 | |
| Carbamide (mmol/l) | 5.93 ± 1.93 | 5.51 ± 1.56 | 0.044 | |
| Creatinine (umol/l) | 72.28 ± 23.08 | 66.90 ± 16.65 | 0.029 | |
| Angina pectoris (n, %) | ||||
| Stable angina pectoris | 22 (6.6) | 5 (4.9) | ||
| Unstable angina pectoris | 278 (83.0) | 88 (85.4) | 0.545 | |
| ST-elevation MI | 15 (4.5) | 2 (1.9) | ||
| Non ST-elevation MI | 20 (6.0) | 8 (7.8) | ||
| LVEDD (mm) | 47.91 ± 4.48 | 47.74 ± 5.08 | 0.736 | |
| LADs (mm) | 37.41 ± 3.82 | 37.29 ± 4.03 | 0.788 | |
| Mitral E/A | 0.86 ± 0.35 | 0.88 ± 0.42 | 0.689 | |
| LVEF | 60.72 ± 8.65 | 60.61 ± 9.22 | 0.913 | |
| NYHA (n, %) | ||||
| I | 44 (13.1) | 12 (11.7) | ||
| II | 262 (80.3) | 83 (80.6) | 0.590 | |
| III | 22 (6.6) | 8 (7.8) | ||
| Lung function (%predicted) | ||||
| VC | 79.39 ± 18.44 | 78.29 ± 20.41 | 0.607 | |
| FVC | 84.59 ± 18.17 | 82.84 ± 20.94 | 0.408 | |
| FEV1 | 85.83 ± 17.71 | 82.69 ± 20.35 | 0.129 | |
| FEV1/FVC | 107.07 ± 12.60 | 105.50 ± 13.93 | 0.282 | |
| MVV | 76.04 ± 24.89 | 68.30 ± 20.75 | 0.004 | |
| Inspiratory muscle strength | ||||
| Pi-max (cmH2O) | 88.61 ± 26.05 | 80.69 ± 25.13 | 0.007 | |
| Hypertension (n, %) | 250 (74.6) | 71 (68.9) | 0.253 | |
| Diabetes (n, %) | 160 (47.8) | 42 (40.8) | 0.214 | |
| Hyperlipidemia (n, %) | 101 (30.1) | 32 (31.1) | 0.859 | |
| Valvular disease (n, %) | 78 (23.3) | 25 (24.3) | 0.836 | |
| Cerebrovascular disease (n, %) | 102 (30.4) | 36 (35.0) | 0.390 | |
| Extracorporeal circulation (n, %) | 268 (80.0) | 88 (85.4) | 0.216 | |
| Operation time (min) | 231.43 ± 59.47 | 264.89 ± 81.58 | < 0.001 | |
| Number of grafts | 3.60 ± 0.85 | 3.70 ± 0.84 | 0.316 | |
| IABP (n, %) | 4 (1.2) | 9 (8.7) | < 0.001 | |
| Duration of mechanical ventilation (h) | 9.47 ± 6.94 | 35.55 ± 74.42 | 0.001 | |
| 24 h Blood glucose level (mmol/l) | 9.04 ± 2.10 | 9.93 ± 3.03 | 0.006 | |
| Blood transfusion (n, %) | 121 (36.1) | 49 (47.6) | 0.037 | |
| Lengh of stay (day) | 8.73 ± 3.39 | 12.74 ± 9.12 | < 0.001 | |
BMI body mass index, MI myocardial infarction, LVEDD left ventricular end diastolic diameter, LADs left atrial diameter, Mitral E/A mitral peak velocity of early filling (E) to mitral peak velocity of late filling (A), LVEF left ventricular ejection fraction, NYHA New York Heart Association, EuroSCORE European system for cardiac operative risk evaluation, VC inspiratory vital capacity, FVC forced vital capacity, FEV forced expiratory volume in the first second of expiration, MVV maximal voluntary ventilation, IABP intra-aortic balloon pump.
Physical performance of the patients with and without clinically significant PPCs.
| Characteristics | Control ( | Clinically significant PPCs ( | Statistics | |
|---|---|---|---|---|
| Grip/weight (kg/kg) | 0.43 ± 0.11 | 0.36 ± 0.11 | < 0.001 | |
| Gait speed (m/s) | 1.00 ± 0.17 | 0.85 ± 0.21 | < 0.001 | |
| TUG (s) | 7.79 ± 1.77 | 10.40 ± 3.65 | < 0.001 | |
| IPAQ high level (n, %) | 72 (21.5) | 14 (13.6) | 0.023 | |
| ADL | 87.78 ± 6.96 | 85.87 ± 8.81 | 0.024 | |
TUG timed up and go, IPAQ international physical activity questionnaire, ADL activities of daily life.
Univariate logistic regression models of influencing factors and clinically significant PPCs.
| Variables | Standard error | Wald | OR (95% CI) | ||
|---|---|---|---|---|---|
| Gait/weight (kg/kg × 10) | − 0.595 | 0.113 | 27.498 | < 0.001 | 0.552 (0.442–0.689) |
| Grip speed (m/s × 10) | − 0.520 | 0.077 | 46.033 | < 0.001 | 0.594 (0.511–0.691) |
| TUG (s) | 0.455 | 0.060 | 57.805 | < 0.001 | 1.576 (1.402–1.773) |
| Age (y) | 0.033 | 0.014 | 5.359 | 0.021 | 1.034 (1.005–1.063) |
| Female | 0.583 | 0.239 | 5.970 | 0.015 | 1.792 (1.122–2.862) |
| BMI (kg/m2) | − 0.045 | 0.035 | 1.607 | 0.205 | 0.956 (0.892–1.025) |
| Heart rate (bpm) | − 0.029 | 0.010 | 8.032 | 0.005 | 0.971 (0.952–0.991) |
| Smoker | 0.676 | 0.230 | 8.613 | 0.003 | 1.966 (1.252–3.087) |
| EuroSCORE | 0.244 | 0.062 | 15.569 | < 0.001 | 1.276 (1.130–1.440) |
| 0.780 | |||||
| Low | 1.00 (reference) | ||||
| Medium | − 0.368 | 0.262 | 1.972 | 0.160 | 0.692 (0.414–1.157) |
| High | − 0.809 | 0.363 | 4.970 | 0.026 | 0.445 (0.219–0.907) |
| ADL | − 0.031 | 0.014 | 4.945 | 0.026 | 0.969 (0.943–0.996) |
| Inspiratory muscle strength (cmH2O) | − 0.012 | 0.005 | 7.189 | 0.007 | 0.988 (0.979–0.997) |
| MVV (%predicted) | − 0.014 | 0.005 | 7.943 | 0.005 | 0.986 (0.976–0.996) |
| Carbamide (mmol/l) | − 0.148 | 0.073 | 4.060 | 0.044 | 0.863 (0.747–0.996) |
| Creatinine (umol/l) | − 0.017 | 0.007 | 5.255 | 0.022 | 0.984 (0.970–0.998) |
| Hypertension | − 0.282 | 0.247 | 1.300 | 0.254 | 0.754 (0.465–1.225) |
| Diabetes | − 0.284 | 0.228 | 1.542 | 0.214 | 0.753 (0.481–1.178) |
| Hyperlipidemia | 0.043 | 0.244 | 0.031 | 0.859 | 1.044 (0.647–1.684) |
| Operation time (min) | 0.007 | 0.002 | 18.084 | < 0.001 | 1.007 (1.004–1.010) |
| Duration of mechanical ventilation (h) | 0.062 | 0.012 | 27.956 | < 0.001 | 1.064 (1.040–1.089) |
| IABP | 2.070 | 0.612 | 11.431 | 0.001 | 7.923 (2.387–26.301) |
| Blood transfusion | 0.473 | 0.228 | 4.314 | 0.038 | 1.605 (1.027–2.508) |
TUG timed up and go, BMI body mass index, IPAQ International physical activity questionnaire, ADL activities of daily life, MVV maximal voluntary ventilation, IABP intra-aortic balloon pump.
Multivariate logistic regression models of physical performance and clinically significant PPCs.
| Variables | Model 1a | Model 2b | ||
|---|---|---|---|---|
| Grip/weight (kg/kg) | 0.471 (0.353–0.630) | < 0.001 | 0.510 (0.363–0.715) | < 0.001 |
| Gait speed (m/s) | 0.591 (0.503–0.693) | < 0.001 | 0.619(0.517–0.741) | < 0.001 |
| TUG (s) | 1.641 (1.436–1.876) | < 0.001 | 1.617 (1.379–1.895) | < 0.001 |
TUG timed up and go.
aModel 1, age, gender, BMI.
bModel 2, age, gender, BMI, Heart rate, Smoker, EuroSCORE, IPAQ, ADL, Inspiratory muscle strength, MVV, Carbamide, Creatinine, Hypertension, Diabetes, Hyperlipidemia, Operation time, Duration of mechanical ventilation, IABP, Blood transfusion.
AUC and cutoff value of physical performance indicators for predicting clinically significant PPCs in CABG patients.
| AUC (95% | Cutoff | Sensitivity (%) | Specificity (%) | ||
|---|---|---|---|---|---|
| Grip/weight (kg/kg) | 0.682 (0.621–0.743) | < 0.001 | 0.365 | 59.2 | 72.5 |
| Gait speed (m/s) | 0.754 (0.693–0.816) | < 0.001 | 0.845 | 64.1 | 82.4 |
| TUG (s) | 0.765 (0.707–0.823) | < 0.001 | 9.110 | 66.0 | 83.3 |
| Integrated model | 0.792 (0.734–0.849) | < 0.001 | 0.285 | 68.9 | 84.8 |
TUG timed up-and-go, AUC the are under the receiver operating characteristic curve.
Figure 2Integrated sensitivity and specificity of grip/weight, gait speed and TUG for PPCs prediction in CABG patients.